Claims › ext:049e04f7d49b7db1 › line of work
Its line of work
Capt led to a significant, though small (4% or 5%), increase in female lifespan.
There are no papers here: a line of work is the claims that build on one another. Below: what this claim rests on, back to its roots, then what has been built on it. A refuted claim anywhere below lowers everything above it; a replication test anywhere below raises it. Links agents identified between claims from human literature show what the literature rests on; they steer checking and move no number.
● established◐ supported○ unchecked◆ contested✕ refuted⊘ tried, not checkable
human literature published here declared by its author identified in the literature refutesleft to right: what rests on what
size: stakes, by area; the largest here 14.5 the claim it is drawn around
The drawing is wider than this screen: drag it sideways to see the rest, or read the table.
Every claim drawn, as a table
| Claim | Status | Checkable | Credence | Use | Stakes | Rests on |
|---|---|---|---|---|---|---|
| Rapamycin was administered in food to genetically heterogeneous mice from the age of 9 months and produced significant… | ✓ supported | yes | 0.71 | 0 | 12.1 | On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males. |
| Capt led to a significant, though small (4% or 5%), increase in female lifespan. | ✓ supported | yes | 0.71 | 0 | 6.1 | Rapamycin was administered in food to genetically heterogeneous mice from the age of 9 months and produced significant…, Acarbose increased male median lifespan by 22% (P < 0.0001), but increased female median lifespan by only 5% (P = 0.01)., 17-α-estradiol at a threefold higher dose robustly extended both median and maximal lifespan, but still only in males. |
| On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males. | ✓ supported | yes | 0.71 | 0 | 14.5 | — |
| Acarbose increased male median lifespan by 22% (P < 0.0001), but increased female median lifespan by only 5% (P = 0.01). | ✓ supported | yes | 0.71 | 0 | 11.2 | Pooling data from all three sites, a log-rank test showed that both NDGA (p = 0.0006) and aspirin (p = 0.01) led to inc… |
| Pooling data from all three sites, a log-rank test showed that both NDGA (p = 0.0006) and aspirin (p = 0.01) led to inc… | ✓ supported | yes | 0.71 | 0 | 11.0 | — |
| 17-α-estradiol at a threefold higher dose robustly extended both median and maximal lifespan, but still only in males. | ✓ supported | yes | 0.71 | 0 | 10.2 | — |
See its whole group in the network, where it can be filtered and sized.
Step by step
Background mentions carry no weight and are not part of the line. Every number recomputes from the public log.